{"id":458398,"date":"2021-03-16T07:18:32","date_gmt":"2021-03-16T11:18:32","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=458398"},"modified":"2021-03-16T07:18:32","modified_gmt":"2021-03-16T11:18:32","slug":"creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\/","title":{"rendered":"Creative Medical Technology Holdings, Inc. Announces FDA Acknowledgment of IND Application for ImmCelz\u00ae to Treat Stroke"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">PHOENIX<\/span>, <span class=\"xn-chron\">March 16, 2021<\/span> \/PRNewswire\/ &#8212;<b>\u00a0<\/b><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3098020-1&amp;h=2587251135&amp;u=https%3A%2F%2Fwww.creativemedicaltechnology.com%2F&amp;a=Creative+Medical+Technology+Holdings%2C+Inc.\" rel=\"nofollow noopener noreferrer\">Creative Medical Technology Holdings, Inc.<\/a>\u00a0(OTC: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to Immunotherapy, Urology, Neurology and Orthopedics, today announced that the FDA issued IND Number 27375 to the Company in connection with its Clinical Trial application to use ImmCelz<sup>\u00ae<\/sup> to treat stroke victims. <\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/926061\/Creative_Medical_Technology_Holdings_Inc_Logo.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/926061\/Creative_Medical_Technology_Holdings_Inc_Logo.jpg\" title=\"Creative Medical Technology Holdings, Inc. Logo (PRNewsfoto\/Creative Medical Technology Hol)\" alt=\"Creative Medical Technology Holdings, Inc. Logo (PRNewsfoto\/Creative Medical Technology Hol)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>The ImmCelz<sup>\u00ae<\/sup>\u00a0treatment involves utilization of stem cells outside of the body to &#8220;reprogram&#8221; the patient&#8217;s own immune cells so as to endow the immune cells with regenerative properties.\u00a0 In contrast to other stem cell based approaches, the immune cells are significantly smaller in size than stem cells and are believed to more effectively penetrate areas of the damaged tissue and induce regeneration.<\/p>\n<p>&#8220;This is a major milestone for the Company,&#8221; exclaimed <span class=\"xn-person\">Timothy Warbington<\/span>, President and CEO of the Company.\u00a0&#8220;We look forward to hearing back from the FDA and moving ImmCelz<sup>\u00ae<\/sup> rapidly to the clinic.&#8221; <\/p>\n<p>\n        <b>About Creative Medical Technology Holdings<\/b>\n      <\/p>\n<p>Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company specializing in regenerative medicine-stem cell technology in the fields of immunotherapy, urology, neurology and orthopedics, and is listed on the OTC under the ticker symbol CELZ. For further information about the company, please visit <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3098020-1&amp;h=2924595856&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2456739-1%26h%3D2617719630%26u%3Dhttp%253A%252F%252Fwww.creativemedicaltechnology.com%252F%26a%3Dwww.creativemedicaltechnology.com&amp;a=www.creativemedicaltechnology.com\" rel=\"nofollow noopener noreferrer\">www.creativemedicaltechnology.com<\/a><b>.\u00a0 <\/b><\/p>\n<p>\n        <b>Forward Looking Statements<\/b>\n      <\/p>\n<p>OTC Markets has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming clinical trials and laboratory results, marketing efforts, funding, etc. Forward-looking statements address future events and conditions and, therefore, involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. See the periodic and other reports filed by Creative Medical Technology Holdings, Inc. with the Securities and Exchange Commission and available on the Commission&#8217;s website at <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3098020-1&amp;h=1166981151&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2456739-1%26h%3D195822705%26u%3Dhttp%253A%252F%252Fwww.sec.gov%252F%26a%3Dwww.sec.gov&amp;a=www.sec.gov\" rel=\"nofollow noopener noreferrer\">www.sec.gov<\/a>.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA10700&amp;sd=2021-03-16\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke-301248038.html\">http:\/\/www.prnewswire.com\/news-releases\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke-301248038.html<\/a><\/p>\n<p>SOURCE  Creative Medical Technology Holdings, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LA10700&amp;Transmission_Id=202103160715PR_NEWS_USPR_____LA10700&amp;DateId=20210316\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire PHOENIX, March 16, 2021 \/PRNewswire\/ &#8212;\u00a0Creative Medical Technology Holdings, Inc.\u00a0(OTC: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to Immunotherapy, Urology, Neurology and Orthopedics, today announced that the FDA issued IND Number 27375 to the Company in connection with its Clinical Trial application to use ImmCelz\u00ae to treat stroke victims. The ImmCelz\u00ae\u00a0treatment involves utilization of stem cells outside of the body to &#8220;reprogram&#8221; the patient&#8217;s own immune cells so as to endow the immune cells with regenerative properties.\u00a0 In contrast to other stem cell based approaches, the immune cells are significantly smaller in size than stem cells and are believed to more effectively penetrate areas of the damaged tissue and induce regeneration. &#8220;This is &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Creative Medical Technology Holdings, Inc. Announces FDA Acknowledgment of IND Application for ImmCelz\u00ae to Treat Stroke&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-458398","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Creative Medical Technology Holdings, Inc. Announces FDA Acknowledgment of IND Application for ImmCelz\u00ae to Treat Stroke - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Creative Medical Technology Holdings, Inc. Announces FDA Acknowledgment of IND Application for ImmCelz\u00ae to Treat Stroke - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire PHOENIX, March 16, 2021 \/PRNewswire\/ &#8212;\u00a0Creative Medical Technology Holdings, Inc.\u00a0(OTC: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to Immunotherapy, Urology, Neurology and Orthopedics, today announced that the FDA issued IND Number 27375 to the Company in connection with its Clinical Trial application to use ImmCelz\u00ae to treat stroke victims. The ImmCelz\u00ae\u00a0treatment involves utilization of stem cells outside of the body to &#8220;reprogram&#8221; the patient&#8217;s own immune cells so as to endow the immune cells with regenerative properties.\u00a0 In contrast to other stem cell based approaches, the immune cells are significantly smaller in size than stem cells and are believed to more effectively penetrate areas of the damaged tissue and induce regeneration. &#8220;This is &hellip; Continue reading &quot;Creative Medical Technology Holdings, Inc. Announces FDA Acknowledgment of IND Application for ImmCelz\u00ae to Treat Stroke&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-16T11:18:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/926061\/Creative_Medical_Technology_Holdings_Inc_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Creative Medical Technology Holdings, Inc. Announces FDA Acknowledgment of IND Application for ImmCelz\u00ae to Treat Stroke\",\"datePublished\":\"2021-03-16T11:18:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\\\/\"},\"wordCount\":346,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/926061\\\/Creative_Medical_Technology_Holdings_Inc_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\\\/\",\"name\":\"Creative Medical Technology Holdings, Inc. Announces FDA Acknowledgment of IND Application for ImmCelz\u00ae to Treat Stroke - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/926061\\\/Creative_Medical_Technology_Holdings_Inc_Logo.jpg\",\"datePublished\":\"2021-03-16T11:18:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/926061\\\/Creative_Medical_Technology_Holdings_Inc_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/926061\\\/Creative_Medical_Technology_Holdings_Inc_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Creative Medical Technology Holdings, Inc. Announces FDA Acknowledgment of IND Application for ImmCelz\u00ae to Treat Stroke\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Creative Medical Technology Holdings, Inc. Announces FDA Acknowledgment of IND Application for ImmCelz\u00ae to Treat Stroke - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\/","og_locale":"en_US","og_type":"article","og_title":"Creative Medical Technology Holdings, Inc. Announces FDA Acknowledgment of IND Application for ImmCelz\u00ae to Treat Stroke - Market Newsdesk","og_description":"PR Newswire PHOENIX, March 16, 2021 \/PRNewswire\/ &#8212;\u00a0Creative Medical Technology Holdings, Inc.\u00a0(OTC: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to Immunotherapy, Urology, Neurology and Orthopedics, today announced that the FDA issued IND Number 27375 to the Company in connection with its Clinical Trial application to use ImmCelz\u00ae to treat stroke victims. The ImmCelz\u00ae\u00a0treatment involves utilization of stem cells outside of the body to &#8220;reprogram&#8221; the patient&#8217;s own immune cells so as to endow the immune cells with regenerative properties.\u00a0 In contrast to other stem cell based approaches, the immune cells are significantly smaller in size than stem cells and are believed to more effectively penetrate areas of the damaged tissue and induce regeneration. &#8220;This is &hellip; Continue reading \"Creative Medical Technology Holdings, Inc. Announces FDA Acknowledgment of IND Application for ImmCelz\u00ae to Treat Stroke\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-16T11:18:32+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/926061\/Creative_Medical_Technology_Holdings_Inc_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Creative Medical Technology Holdings, Inc. Announces FDA Acknowledgment of IND Application for ImmCelz\u00ae to Treat Stroke","datePublished":"2021-03-16T11:18:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\/"},"wordCount":346,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/926061\/Creative_Medical_Technology_Holdings_Inc_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\/","name":"Creative Medical Technology Holdings, Inc. Announces FDA Acknowledgment of IND Application for ImmCelz\u00ae to Treat Stroke - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/926061\/Creative_Medical_Technology_Holdings_Inc_Logo.jpg","datePublished":"2021-03-16T11:18:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/926061\/Creative_Medical_Technology_Holdings_Inc_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/926061\/Creative_Medical_Technology_Holdings_Inc_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/creative-medical-technology-holdings-inc-announces-fda-acknowledgment-of-ind-application-for-immcelz-to-treat-stroke\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Creative Medical Technology Holdings, Inc. Announces FDA Acknowledgment of IND Application for ImmCelz\u00ae to Treat Stroke"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/458398","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=458398"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/458398\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=458398"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=458398"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=458398"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}